| |
| On April 29, 2008 the Company completed its Series B debenture offering in Israel. Ampal accepted subscriptions in the amount of NIS 577.8 million (approximately $165.7 million) for its Series B debentures. The debentures are linked to the Israeli consumer price index and will carry an annual interest rate of 6.6%. The notes shall rank pari passu with our unsecured indebtedness. The notes will be repaid in five equal annual installments commencing on January 31, 2012, and the interest will be paid semi-annually. As of September 30, 2008, the outstanding debt under the notes amounts to $176.1 million, due to the change in valuation of the New Israeli Shekel as compared to the U.S. dollar. The Company deposited an amount of $44,551,773 with Clal Finance Trusties 2007 Ltd. in accordance with a trust agreement dated April 6, 2008 to secure the first three years worth of payments of interest on the debentures. As of September 30, 2008, the outstanding amount of the deposit was $39 million |
| |
| Midroog Ltd., an affiliate of Moody’s Investors Service, initially rated the Company’s Series A debentures as A3. On March 27, 2008 Midroog raised the rating of the Series A debentures to A2 and rated the Series B debentures as A2. On September 15, 2008 Midroog reduced the rating to A3. |
| |
| Other long term borrowings in the amount of $0.2 million are linked to the Consumer Price Index in Israel, mature between 2008 and 2010 and bear annual interest of 5.7%. |
| |
| As of September 30, 2008, Gadot had $0.2 million outstanding under its convertible debentures. The debentures are linked to the Consumer Price Index in Israel, bear annual interest at the rate of 6.5%, and are repayable in two equal annual installments on December 5, 2008 and 2009. The debentures are convertible into ordinary shares of Gadot until December 5, 2009. |
| |
| As of September 30, 2008, Gadot had $13.3 million outstanding under its other debentures. These debentures are not convertible into shares and are repayable in five equal annual installments on September 15 of each of the years 2008 through 2012. The outstanding balance of the principal of the debentures bears annual interest at the rate of 5.3%. The principal and interest of the debentures are linked to the Consumer Price Index in Israel and the interest is payable in semi-annual installments on March 15 and September 15 of each of the years 2006 through 2012. |
| |
| As of September 30, 2008, Gadot has short term loans payable in the amount of $106.3 million and long term loans payable in the amount of $55.3 million. The various short term loans payable are either unlinked or linked to the Euro and bear interest at rates between 5.73% to 6.09%. The various long term loans payable are either unlinked, linked to the Consumer Price Index in Israel or linked to the Euro and bear interest at rates between 4.82% to 6.9%. |
| |
| The weighted average interest rates and the balances of these short-term borrowings at September 30, 2008 and December 31, 2007 were 5.3% on $154.2 million and 6.3% on $136.6 million, respectively. |
| |
| As of September 30, 2008, the Company had issued guarantees on certain outstanding loans to its investees and subsidiaries in the aggregate principal amount of $44.3 million. These include: |
| |
| FORWARD LOOKING STATEMENTS |
| |
| This Quarterly Report (including but not limited to factors discussed above, in the “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” as well as those discussed elsewhere in this Quarterly Report on Form 10-Q) includes forward-looking statements (within the meaning of Section 27A of the Securities Act of 1993 and Section 21E of the Securities Exchange Act of 1934) and information relating to the Company that are based on the beliefs of management of the Company as well as assumptions made by and information currently available to the management of the Company. When used in this Quarterly Report, the words “anticipate,” “believe,” “estimate,” “expect,” “intend,” “plan,” and similar expressions, as they relate to the Company or the management of the Company, identify forward-looking statements. Such statements reflect the current views of the Company with respect to future events or future financial performance of the Company, the outcome of which is subject to certain risks and other factors which could cause actual results to differ materially from those anticipated by the forward-looking statements, including among others, the economic and political conditions in Israel and the Middle East and the global business and economic conditions in the different sectors and markets where the Company’s portfolio companies operate. |
| |
| Should any of those risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results or outcomes may vary from those described herein as anticipated, believed, estimated, expected, intended or planned. These risks and uncertainties may include, but are not limited to, those described in this report, in Part II, Item 1A. Risk Factors and elsewhere in our Annual Report on Form 10-K for the year ended December 31, 2007, and those described from time to time in our future reports filed with the Securities and Exchange Commission. The Company assumes no obligation to update or revise any forward-looking statements. |
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
MARKET RISKS AND SENSITIVITY ANALYSIS
The Company is exposed to various market risks, including changes in interest rates, foreign currency exchange rates, index rates and equity price changes. The following analysis presents the hypothetical loss in earnings, cash flows and fair values of the financial instruments which were held by the Company at September 30, 2008, and are sensitive to the above market risks.
During the nine months ended September 30, 2008, there have been no material changes in the market risk exposures facing the Company as compared to those the Company faced in the fiscal year ended December 31, 2007.
Interest Rate Risks
On May 15, 2008, the Company entered into a swap agreement with respect to its Series B debentures, in the principal amount of $165.7 million, due 2016. As a result of these agreements the Company is currently paying an effective interest rate of LIBOR plus 5.12% on $43.9 million of these debentures, as compared to the original 6.6% fixed rate which is linked to the Israeli consumer price index.
As of September 30, 2008, the value of the currency swap resulted in a $0.8 million decrease in other assets and a corresponding increase in interest expense.
As of September 30, 2008, the Company had financial assets totaling $146.9 million and financial liabilities totaling $678.0 million. For fixed rate financial instruments, interest rate changes affect the fair market value but do not impact earnings or cash flows. Conversely, for variable rate financial instruments, interest rate changes generally do not affect the fair market value but do impact future earnings and cash flows, assuming other factors are held constant.
As of September 30, 2008, the Company did not have fixed rate financial assets and had variable rate financial assets of $146.9 million. A ten percent decrease in interest rates would not increase the unrealized fair value of the fixed rate assets.
As of September 30, 2008, the Company had fixed rate debt of $372.5 million and variable rate debt of $305.4 million. A ten percent decrease in interest rates would increase the unrealized fair value of the financial debts in the form of the fixed rate debt by approximately $7.4 million.
The net decrease in earnings and cash flows for the next year resulting from a ten percent interest rate increase would be approximately $1.5 million, holding other variables constant.
24
Foreign Currency Exchange Rate Sensitivity Analysis
The Company’s exchange rate exposure on its financial instruments results from its investments and ongoing operations. As of September 30, 2008, the Company had open foreign exchange forward contracts to purchase U.S. Dollars and sell Euros in the amount of $3.9 million, contracts to purchase Euros and sell Pounds in the amount of $0.3 million and contracts to sell U.S. Dollars and buy Euros in the amount of $1.3 million. Holding other variables constant, if there were a ten percent devaluation of each of the foreign currency, the Company’s cumulative translation loss reflected in the Company’s accumulated other comprehensive loss would increase by $5.9 million, and regarding the statements of operations, a ten percent devaluation of the U.S. Dollar exchange rate would result in a net increase in earnings and cash flows of $31.2 million, and a ten percent devaluation of the Euro exchange rate would result in a net increase in earnings and cash flows of $3.0 million.
On May 15, 2008, the Company entered into a swap agreement with respect to its Series B debentures, in the principal amount of $165.7 million, due 2016. As a result of these agreements the Company is currently paying an effective interest rate of LIBOR plus 5.12% on $43.9 million of these notes, as compared to the original 6.6% fixed rate which is linked to the Israeli consumer price index. As of September 30, 2008, the value of the currency swap resulted in a $0.8 million decrease in other assets and a corresponding increase in interest expense.
Equity Price Risk
The Company’s investments at September 30, 2008 included trading marketable securities which are recorded at a fair value of $6.3 million, including a net unrealized gain of $0.8 million, and $56.4 million of trading securities that are classified as available for sale, including a net unrealized loss of $0.8 million. Those securities have exposure to equity price risk. The estimated potential loss in fair value resulting from a hypothetical ten percent decrease in prices quoted on stock exchanges is approximately $6.3 million. There will be no impact on cash flow resulting from a hypothetical ten percent decrease in prices quoted on stock exchanges.
ITEM 4. CONTROLS AND PROCEDURES
Disclosure Controls and Procedures
The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the Company’s disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this report. Based on such evaluation, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of such period, the Company’s disclosure controls and procedures are effective. Notwithstanding the foregoing, a control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that it will detect or uncover failures within the Company to disclose material information otherwise required to be set forth in the Company’s periodic reports.
Internal Control Over Financial Reporting
There have not been any changes in the Company’s internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the fiscal quarter to which this report relates that have materially affected, or are reasonably likely to materially affect the Company’s internal control over financial reporting.
25
| | |
Part II – OTHER INFORMATION |
| | |
Item 1. | Legal Proceedings: |
| |
| On January 1, 2002, Galha filed a suit against the Company and other parties, including directors of Paradise Industries Ltd. (“Paradise”) appointed by the Company, in the Tel Aviv District Court, in the amount of NIS 11,560,000 ($3 million). Galha claimed that the Company, which was a shareholder of Paradise, and another shareholder of Paradise, misused funds that were received by Paradise from an insurance company for the purpose of reconstructing an industrial building owned by Galha and used by Paradise which burnt down. Paradise is currently involved in liquidation proceedings. Ampal entered into a guarantee in favor of Galha for a benefit of a defendant for the payment of an amount of up to approximately NIS 4,381,000 ($1,281,000) if there is final judgment against the Company. |
| |
| On May 26, 2003, the Company and the directors of Paradise appointed by the Company filed a third party claim against Arieh Israeli Insurance Company Ltd. (“Arieh”) in the Tel Aviv District Court claiming that, to the extent the court decides that the directors of Paradise appointed by the Company will have to pay any amounts to Galha, Arieh will pay such amounts on behalf of the directors in accordance with the Directors and Officers insurance policy that the Company had at that time with Arieh. Arieh filed a statement of defense and stated that the policy does not cover the claim. At this stage, the Company cannot estimate the impact this claim will have on it. In March 2008, the dispute was submitted to mediation by order of the court, with the consent of the parties. See also Part II – Item 1, “Legal Proceedings”, of the Company’s Quarterly Reports on Form 10-Q for the periods ended March 31 and June 30, 2008. |
| | |
Item 1A. | RISK FACTORS |
| | |
| In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2007, which could materially affect our business, financial condition or future results. The risks described in our Annual Report on Form 10-K are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results. |
| | |
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds. |
| |
| None. |
| |
Item 3. | Defaults upon Senior Securities |
| |
| None. |
| |
Item 4. | Submission of Matters to a Vote of Security Holders. |
| |
| None. |
| |
Item 5. | Other Information. |
| |
| None. |
| |
Item 6. | Exhibits. |
| | |
(a) | | Exhibits: |
| | |
4.a | | English Translation of the original Hebrew language Trust Deed dated, April 6, 2008, between Ampal American Israel Corporation and Clal Financial Trusts 2007 Ltd., and its amendments (Filed as exhibit 4.a to Form 10-Q, for the quarter ended March 31, 2008, and incorporated herein by reference). |
| | |
11.1 | | Schedule Setting Forth Computation of Earnings Per Share of Class A Stock. |
| | |
31.1 | | Certification of Yosef A. Maiman pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| | |
31.2 | | Certification of Irit Eluz pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| | |
32.1 | | Certification of Yosef A. Maiman and Irit Eluz pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
26
AMPAL-AMERICAN ISRAEL CORPORATION AND SUBSIDIARIES
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| | |
| AMPAL-AMERICAN ISRAEL CORPORATION |
| | |
| By: /s/ Yosef A. Maiman | |
|
| |
| Yosef A. Maiman | |
| Chairman of the Board | |
| President & Chief Executive Officer | |
| (Principal Executive Officer) | |
| | |
| By: /s/ Irit Eluz | |
|
| |
| Irit Eluz | |
| CFO and Senior Vice President, | |
| Finance and Treasurer | |
| (Principal Financial Officer) | |
| | |
| By: /s/ Zahi Ben-Atav | |
|
| |
| Zahi Ben-Atav | |
| VP Accounting and Controller | |
| (Principal Accounting Officer) | |
| | |
Date: November 5, 2008 | | |
27
AMPAL-AMERICAN ISRAEL CORPORATION AND SUBSIDIARIES
Exhibit Index
| | |
Exhibit No. | | Description |
| | |
4.a | | English Translation of the original Hebrew language Trust Deed, dated April 6, 2008, between Ampal American Israel Corporation and Clal Financial Trusts 2007 Ltd., and its amendments (Filed as exhibit 4.a to Form 10-Q, for the quarter ended March 31, 2008, and incorporated herein by reference). |
| | |
11.1 | | Schedule Setting Forth Computation of Earnings Per Share of Class A Stock. |
| | |
31.1 | | Certification of Yosef A. Maiman pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| | |
31.2 | | Certification of Irit Eluz pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| | |
32.1 | | Certification of Yosef A. Maiman and Irit Eluz pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
28